
John H. Morehead Iii
Examiner (ID: 15715)
| Most Active Art Unit | 2664 |
| Art Unit(s) | 2664, 2699, 2697, 2639, 2638, 2622 |
| Total Applications | 735 |
| Issued Applications | 598 |
| Pending Applications | 48 |
| Abandoned Applications | 100 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4595582
[patent_doc_number] => 07981650
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Fusion proteins between plant cell-wall degrading enzymes, and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/990339
[patent_app_country] => US
[patent_app_date] => 2006-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11748
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981650.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990339
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990339 | Fusion proteins between plant cell-wall degrading enzymes, and their uses | Jul 25, 2006 | Issued |
Array
(
[id] => 5485282
[patent_doc_number] => 20090275047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLATE CYCLASE'
[patent_app_type] => utility
[patent_app_number] => 11/996187
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 31649
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275047.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996187
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996187 | CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLATE CYCLASE | Jul 20, 2006 | Abandoned |
Array
(
[id] => 5374201
[patent_doc_number] => 20090311762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'OXIDOREDUCTASES FOR THE STEREOSELECTIVE REDUCTION OF KETO COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/996968
[patent_app_country] => US
[patent_app_date] => 2006-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14080
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311762.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996968 | OXIDOREDUCTASES FOR THE STEREOSELECTIVE REDUCTION OF KETO COMPOUNDS | Jul 19, 2006 | Abandoned |
Array
(
[id] => 401126
[patent_doc_number] => 07291490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-06
[patent_title] => 'Nucleic acid fragment encoding an NRPS for the biosynthesis of anthramycin'
[patent_app_type] => utility
[patent_app_number] => 11/481907
[patent_app_country] => US
[patent_app_date] => 2006-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29892
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/291/07291490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11481907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/481907 | Nucleic acid fragment encoding an NRPS for the biosynthesis of anthramycin | Jul 6, 2006 | Issued |
Array
(
[id] => 4612673
[patent_doc_number] => 07989184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-02
[patent_title] => 'Endoribonuclease'
[patent_app_type] => utility
[patent_app_number] => 11/997071
[patent_app_country] => US
[patent_app_date] => 2006-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4444
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/989/07989184.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997071
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997071 | Endoribonuclease | Jul 3, 2006 | Issued |
Array
(
[id] => 4859437
[patent_doc_number] => 20080268287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Method of Converting Water-Soluble Active Proteins Into Hydrophobic Active Proteins, the Use of the Same for the Preparation of Monomolecular Layers of Oriented Active Proteins, and Devices Comprising the Same'
[patent_app_type] => utility
[patent_app_number] => 12/093031
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4559
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20080268287.pdf
[firstpage_image] =>[orig_patent_app_number] => 12093031
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/093031 | Method of Converting Water-Soluble Active Proteins Into Hydrophobic Active Proteins, the Use of the Same for the Preparation of Monomolecular Layers of Oriented Active Proteins, and Devices Comprising the Same | Jun 29, 2006 | Abandoned |
Array
(
[id] => 376810
[patent_doc_number] => 07311908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-25
[patent_title] => 'Pharmaceutical compositions of fibrinolytic agent'
[patent_app_type] => utility
[patent_app_number] => 11/479214
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4434
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/311/07311908.pdf
[firstpage_image] =>[orig_patent_app_number] => 11479214
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/479214 | Pharmaceutical compositions of fibrinolytic agent | Jun 28, 2006 | Issued |
Array
(
[id] => 6488576
[patent_doc_number] => 20100009405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Biosynthetic process for the preparation of gallidermin'
[patent_app_type] => utility
[patent_app_number] => 11/922494
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 10572
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009405.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922494
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922494 | Biosynthetic process for the preparation of gallidermin | Jun 27, 2006 | Abandoned |
Array
(
[id] => 5689195
[patent_doc_number] => 20060287510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Crystallization of IGF-1'
[patent_app_type] => utility
[patent_app_number] => 11/472121
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31225
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287510.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472121
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472121 | Crystallization of IGF-1 | Jun 19, 2006 | Issued |
Array
(
[id] => 5889821
[patent_doc_number] => 20060276397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Crystallization of IGF-1'
[patent_app_type] => utility
[patent_app_number] => 11/471895
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31220
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276397.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471895
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471895 | Crystallization of IGF-1 | Jun 19, 2006 | Abandoned |
Array
(
[id] => 5688920
[patent_doc_number] => 20060287235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Crystallization of IGF-1'
[patent_app_type] => utility
[patent_app_number] => 11/471912
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31226
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471912 | Crystallization of IGF-1 | Jun 19, 2006 | Issued |
Array
(
[id] => 5609323
[patent_doc_number] => 20060270839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Crystallization of IGF-1'
[patent_app_type] => utility
[patent_app_number] => 11/472122
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31229
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270839.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472122
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472122 | Crystallization of IGF-1 | Jun 19, 2006 | Abandoned |
Array
(
[id] => 4995607
[patent_doc_number] => 20070010952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them'
[patent_app_type] => utility
[patent_app_number] => 11/471290
[patent_app_country] => US
[patent_app_date] => 2006-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 109
[patent_figures_cnt] => 109
[patent_no_of_words] => 13546
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471290
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471290 | Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them | Jun 18, 2006 | Abandoned |
Array
(
[id] => 4984640
[patent_doc_number] => 20070089199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Pufa polyketide synthase systems and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/452138
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 40703
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20070089199.pdf
[firstpage_image] =>[orig_patent_app_number] => 11452138
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/452138 | PUFA polyketide synthase systems and uses thereof | Jun 11, 2006 | Issued |
Array
(
[id] => 5495847
[patent_doc_number] => 20090263875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'METHODS OF GENERATING PROTEIN VARIANTS WITH ALTERED FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 11/915979
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18031
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263875.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915979
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915979 | Methods of generating protein variants with altered function | May 31, 2006 | Issued |
Array
(
[id] => 6460235
[patent_doc_number] => 20100190225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'D-PSICOSE PRODUCTION METHOD BY D-PSICOSE EPIMERASE'
[patent_app_type] => utility
[patent_app_number] => 11/916182
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5260
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190225.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916182
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916182 | D-psicose production method by D-psicose epimerase | May 29, 2006 | Issued |
Array
(
[id] => 5922288
[patent_doc_number] => 20060240464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Novel 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/429599
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90934
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240464.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429599 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor | May 4, 2006 | Issued |
Array
(
[id] => 6457693
[patent_doc_number] => 20100205754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Multi-Copper Oxidase CueO with Dyeability'
[patent_app_type] => utility
[patent_app_number] => 12/084287
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17816
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20100205754.pdf
[firstpage_image] =>[orig_patent_app_number] => 12084287
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/084287 | Deletion mutant of multi-copper oxidase and its use in dyeing | Apr 13, 2006 | Issued |
Array
(
[id] => 4275
[patent_doc_number] => 07811800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'Variant form of urate oxidase and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/918296
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10705
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/811/07811800.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918296
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918296 | Variant form of urate oxidase and use thereof | Apr 10, 2006 | Issued |
Array
(
[id] => 8421581
[patent_doc_number] => 08278069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Identification of a β-1,3-N-acetylgalactosaminyltransferase (CGTE) from Campylobacter jejuni LIO87'
[patent_app_type] => utility
[patent_app_number] => 11/911318
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18007
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11911318
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911318 | Identification of a β-1,3-N-acetylgalactosaminyltransferase (CGTE) from Campylobacter jejuni LIO87 | Apr 6, 2006 | Issued |